What medication is used to treat Thromboangiitis Obliterans (Buerger disease)?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Multiple Choice

What medication is used to treat Thromboangiitis Obliterans (Buerger disease)?

Thromboangiitis Obliterans is a disease where improving microvascular blood flow in the extremities is key, with tobacco cessation as the most important step. Pentoxifylline helps by making red blood cells more deformable and reducing blood viscosity, which improves flow in the small vessels and can lessen claudication and ulcer-related symptoms in Buerger disease. It acts as a rheologic agent to enhance tissue perfusion, which is why it’s used in this condition. Antibiotics aren’t indicated because infection isn’t the primary issue. Heparin isn’t standard therapy for this chronic vasculitis/thrombotic process and hasn’t shown consistent long-term benefit. Statin therapy targets atherosclerotic disease rather than this inflammatory/thrombotic vasculopathy, so it’s not the primary treatment here.

Thromboangiitis Obliterans is a disease where improving microvascular blood flow in the extremities is key, with tobacco cessation as the most important step. Pentoxifylline helps by making red blood cells more deformable and reducing blood viscosity, which improves flow in the small vessels and can lessen claudication and ulcer-related symptoms in Buerger disease. It acts as a rheologic agent to enhance tissue perfusion, which is why it’s used in this condition.

Antibiotics aren’t indicated because infection isn’t the primary issue. Heparin isn’t standard therapy for this chronic vasculitis/thrombotic process and hasn’t shown consistent long-term benefit. Statin therapy targets atherosclerotic disease rather than this inflammatory/thrombotic vasculopathy, so it’s not the primary treatment here.

More practice questions